Your browser doesn't support javascript.
Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.
Bernstein, Adrien N; Talwar, Ruchika; Handorf, Elizabeth; Syed, Kaynaat; Danella, John; Ginzburg, Serge; Belkoff, Laurence; Reese, Adam C; Tomaszewski, Jeffery; Trabulsi, Edouard; Singer, Eric A; Jacobs, Bruce; Kutikov, Alexander; Uzzo, Robert; Raman, Jay D; Guzzo, Thomas; Smaldone, Marc C; Correa, Andres.
  • Bernstein AN; Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Talwar R; Division of Urology, University of Pennsylvania, Philadelphia.
  • Handorf E; Department of Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Syed K; Health Care Improvement Foundation, Philadelphia, Pennsylvania.
  • Danella J; Department of Urology, Geisinger Health System, Danville, Pennsylvania.
  • Ginzburg S; Department of Urology, Einstein Healthcare Network, Philadelphia, Pennsylvania.
  • Belkoff L; Division of Urology, MidLantic Urology/Main Line Health, Bala Cynwyd, Pennsylvania.
  • Reese AC; Department of Urology, Temple University, Philadelphia, Pennsylvania.
  • Tomaszewski J; Division of Urology, Cooper University Health Care, Camden, New Jersey.
  • Trabulsi E; Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Singer EA; Division of Urology, Rutgers Cancer Institute of New Jersey, New Brunswick.
  • Jacobs B; Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Kutikov A; Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Uzzo R; Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Raman JD; Division of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Guzzo T; Division of Urology, University of Pennsylvania, Philadelphia.
  • Smaldone MC; Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Correa A; Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
JAMA Oncol ; 7(10): 1467-1473, 2021 10 01.
Article in English | MEDLINE | ID: covidwho-1320053
ABSTRACT
Importance Early in the COVID-19 pandemic, racial/ethnic minority communities disproportionately experienced poor outcomes; however, the association of the pandemic with prostate cancer (PCa) care is unknown.

Objective:

To assess the association between race and PCa care delivery for Black and White patients during the first wave of the COVID-19 pandemic. Design, Setting, and

Participants:

This multicenter, regional, collaborative, retrospective cohort study compared prostatectomy rates between Black and White patients with untreated nonmetastatic PCa during the COVID-19 pandemic (269 patients from March 16 to May 15, 2020) and prior (378 patients from March 11 to May 10, 2019). Main Outcomes and

Measures:

Prostatectomy rates.

Results:

Of the 647 men with nonmetastatic PCa, 172 (26.6%) were non-Hispanic Black men, and 475 (73.4%) were non-Hispanic White men. Black men were significantly less likely to undergo prostatectomy during the pandemic compared with White patients (1 of 76 [1.3%] vs 50 of 193 [25.9%]; P < .001), despite similar COVID-19 risk factors, biopsy Gleason grade groups, and comparable prostatectomy rates prior to the pandemic (17 of 96 [17.7%] vs 54 of 282 [19.1%]; P = .75). Black men had higher median prostate-specific antigen levels prior to biopsy (8.8 ng/mL [interquartile range, 5.3-15.2 ng/mL] vs 7.2 ng/mL [interquartile range, 5.1-11.1 ng/mL]; P = .04). A linear combination of regression coefficients with an interaction term for year demonstrated an odds ratio for likelihood of surgery of 0.06 (95% CI, 0.01-0.35; P = .002) for Black patients and 1.41 (95% CI, 0.81-2.44; P = .23) for White patients during the pandemic compared with prior to the pandemic. Changes in surgical volume varied by site (from a 33% increase to complete shutdown), with sites that experienced the largest reduction in cancer surgery caring for a greater proportion of Black patients. Conclusions and Relevance In this large multi-institutional regional collaborative cohort study, the odds of PCa surgery were lower among Black patients compared with White patients during the initial wave of the COVID-19 pandemic. Although localized PCa does not require immediate treatment, the lessons from this study suggest systemic inequities within health care and are likely applicable across medical specialties. Public health efforts are needed to fully recognize the unintended consequence of diversion of cancer resources to the COVID-19 pandemic to develop balanced mitigation strategies as viral rates continue to fluctuate.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / Black or African American / White People / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Aged / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Oncol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / Black or African American / White People / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Aged / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Oncol Year: 2021 Document Type: Article